Galectin Inhibitors Drugs Companies Clinical Trials Insight 2023
<!-- Name:DistributionId Value:8808049 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Galectin
Galectin Therapeutics Reports the Positive Outcome of the First Data and Safety…
NORCROSS, Ga., April 14, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, today reported the positive…
UPDATE – Galectin Therapeutics to Present Six Scientific Abstracts at The Liver…
New data regarding the mechanism of action of belapectin to inhibit galectin-3Unique pharmacokinetic profile of belapectin in patients with hepatic insufficiencyInnovating in Liver…